Patents by Inventor Julia Hurwitz

Julia Hurwitz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of sendai virus as a human parainfluenza vaccine
    Publication number: 20060110740
    Abstract: Immunogenic compositions to protect against human parainfluenza (hPIV) virus infection are provided. The compositions comprise an unmodified Sendai virus that can be safely administered to human subjects, particularly young children, to protect against symptoms and health risks associated with hPIV infection.
    Type: Application
    Filed: January 12, 2004
    Publication date: May 25, 2006
    Inventors: Julia Hurwitz, Christopher Coleclough, Karen Slobod, Allen Portner
  • Preparation and use of viral vectors for mixed envelope protein vaccines against human immunodeficiency viruses
    Patent number: 6723558
    Abstract: Polyenv vaccines are provided that comprise mixtures of at least 4 to about 10,000 different recombinant viruses that each express a different HIV env variant or a portion thereof containing both constant and variable regions, as well as methods of making and using such polyenv vaccines and viruses, including the use of the polyenv vaccine, in live, attenuated or inactivated form, for prophylaxis or treatment of HIV infection. The viral vaccines of the invention are optimally combined with a recombinant HIV env booster, or a recombinant HIV env gene DNA priming or boosting vaccine.
    Type: Grant
    Filed: May 10, 2000
    Date of Patent: April 20, 2004
    Assignee: St. Jude Children's Research Hospital
    Inventors: Julia Hurwitz, Christopher Coleclough, Randall Owens, Karen Slobod
  • Bi-functional plasmid that can act as both a DNA vaccine and a recombinant virus vector
    Patent number: 6086891
    Abstract: Polyenv vaccines are provided that comprise mixtures of at least 4 to about 10,000 different recombinant viruses that each express a different HIV env variant or a portion thereof containing both constant and variable regions, as well as methods of making and using such polyenv vaccines and viruses, including the use of the polyenv vaccine, in live, attenuated or inactivated form, for prophylaxis or treatment of HIV infection. The viral vaccines of the invention are optimally combined with a recombinant HIV env booster, or a recombinant HIV env gene DNA priming or boosting vaccine.
    Type: Grant
    Filed: September 21, 1998
    Date of Patent: July 11, 2000
    Assignee: St. Jude Children's Research Hospital
    Inventors: Julia Hurwitz, Christopher Coleclough
  • Preparation and use of viral vectors for mixed envelope protein immunogenic composition against human immunodeficiency viruses
    Patent number: 5846546
    Abstract: Polyenv immunogenic composition are provided that comprise mixtures of at least 4 different recombinant viruses that each express a different HIV env variant or a portion thereof containing both constant and variable regions, as well as methods of making and using such polyenv immunogenic composition and viruses. The immunogenic composition of the invention are optimally combined with a recombinant HIV env booster, or a recombinant HIV env gene DNA priming or boosting vaccine.
    Type: Grant
    Filed: January 23, 1997
    Date of Patent: December 8, 1998
    Assignee: St. Jude Children's Research Hospital
    Inventors: Julia Hurwitz, Karen Slobod